← Back to Search

Group Intervention for Suicidal Thoughts (BRAVA Trial)

N/A

Waitlist Available

Led By Allison Kennedy, PhD

Research Sponsored by Children's Hospital of Eastern Ontario

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be younger than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 weeks

Awards & highlights

BRAVA Trial Summary

This trial assesses the efficacy of a brief group intervention, BRAVA, for adolescents with mild to moderate SI and their caregivers in reducing SI.

Eligible Conditions

Suicidal Thoughts
Suicide and Self-Harm

BRAVA Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Suicidal Ideation

Secondary outcome measures

Attachment

Depression and Anxiety

Family Functioning

BRAVA Trial Design

2Treatment groups

Experimental Treatment

Group I: Group InterventionExperimental Treatment1 Intervention

The intervention will consist of 6 psycho-educational group sessions for caregivers and 6 psycho-educational group sessions for adolescents. Adolescent and caregiver sessions will be held separately and will focus on different issues. Adolescents are taught skills for coping and relating more effectively with others. Caregivers learn about adolescent development, effective parenting and the importance of connection. The groups consist of 6 stand-alone modules permitting rolling entry and prompt access. Youth and Caregivers will receive a weekly text message reminder of their exit assessment date/time, homework from that week's intervention group and crisis resources.

Group II: Enhanced Treatment as UsualExperimental Treatment1 Intervention

Youth and Caregivers will receive a weekly text message reminder of their exit assessment date/time, a mental health tip and crisis resources.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Enhanced Treatment as Usual

2016

Completed Phase 4

~770

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Children's Hospital of Eastern OntarioLead Sponsor

125 Previous Clinical Trials

55,363 Total Patients Enrolled

Mach Gaensslen FoundationOTHER

3 Previous Clinical Trials

560 Total Patients Enrolled

Children's Hospital of Eastern Ontario Research InstituteOTHER

3 Previous Clinical Trials

450 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many individuals have been enlisted in this clinical trial?

"Affirmative. According to data found on clinicaltrials.gov, this research endeavour is seeking participants as of July 25th 2022 -after its inception on April 12th 2021-. 98 individuals will be accepted at a single location."

Answered by AI

Are juveniles below the age of twenty capable of participating in this experimental trial?

"This medical trial requires participants to be aged 13-17, in accordance with its stipulated inclusion criteria."

Answered by AI

Who qualifies as an appropriate participant in this research endeavor?

"This trial seeks 98 adolescents aged 13-17.5 with mild to moderate suicidal ideation (as measured by the HEADS-ED scale) who are interested in participating, have access to a device with internet/email capability and a functioning camera/microphone."

Answered by AI

Are there opportunities for participants to enroll in this trial?

"Yes, indeed. According to records hosted on clinicaltrials.gov, this medical trial was created on April 12th 2021 and is still actively recruiting patients as of July 25th 2022. To date, 98 people have been enrolled from a single research site."

Answered by AI

Recent research and studies

Behaviour Research and TherapyJournal

Assessment of Symptoms of DSM-IV Anxiety and Depression in Children: A Revised Child Anxiety and Depression Scale

Chorpita, Bruce F, Letitia Yim, Catherine Moffitt, Lori A Umemoto, and Sarah E Francis. 2000. “Assessment of Symptoms of DSM-IV Anxiety and Depression in Children: A Revised Child Anxiety and Depression Scale”. Behaviour Research and Therapy. Elsevier BV. doi:10.1016/s0005-7967(99)00130-8.

The Canadian Journal of PsychiatryJournal

Prevalence and Correlates of Youth Suicidal Ideation and Attempts: Evidence from the 2014 Ontario Child Health Study

Georgiades, Katholiki, Khrista Boylan, Laura Duncan, Li Wang, Ian Colman, Anne E. Rhodes, Kathryn Bennett, et al.. 2019. “Prevalence and Correlates of Youth Suicidal Ideation and Attempts: Evidence from the 2014 Ontario Child Health Study”. The Canadian Journal of Psychiatry. SAGE Publications. doi:10.1177/0706743719830031.

Journal of AdolescenceJournal

Effectiveness of an Attachment‐focused Manualized Intervention for Parents of Teens at Risk for Aggressive Behaviour: The Connect Program

Moretti, Marlene M., and Ingrid Obsuth. 2009. “Effectiveness of an Attachment‐focused Manualized Intervention for Parents of Teens at Risk for Aggressive Behaviour: The Connect Program”. Journal of Adolescence. Wiley. doi:10.1016/j.adolescence.2009.07.013.

PediatricsJournal